Vidal Nicole, Mulanga Claire, Bazepeo S.E., Mwamba J.K., Tshimpaka J., Kashi M., Mama N., Valea D., Delaporte Eric, Lepira F., Peeters Martine. (2006). HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). Aids Research and Human Retroviruses, 22 (2), p. 202-206.
Titre du document
HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC)
Vidal Nicole, Mulanga Claire, Bazepeo S.E., Mwamba J.K., Tshimpaka J., Kashi M., Mama N., Valea D., Delaporte Eric, Lepira F., Peeters Martine
Source
Aids Research and Human Retroviruses, 2006,
22 (2), p. 202-206
To study recombination and the natural polymorphism in pol of HIV-1 strains in the Democratic Republic of Congo (DRC) we sequenced the protease and RT genes for 70 HIV-1 strains previously characterized in the env V3-V5 region from a sentinel surveillance study in 2002. For 41 of the 70 (58.6%) strains, the same subtype/CRF designations were observed in pol and env. Twenty-three (32.9%) of 70 pol sequences were complex recombinants involving two to five subtypes as well as fragments that could not be classified into any of the known subtypes. All subtypes were involved in recombination events. Unclassified (U) and env subtype H strains were very likely to be recombinant strains. Overall, many minor mutations were identified in the protease sequences. Although at the time of our study ARV use was not yet widespread in DRC, three strains were identified with one major mutation associated with drug resistance: L90M and M46L in protease and K103N in RT.
